Information on transaction in Company shares under Article 19 MAR

Current report no. 3/2025

Drafting date: 27 January 2025

Subject: Information on transaction in Company shares under Article 19 MAR

Legal basis: Article 19(3) MAR – information on transactions carried out by persons discharging managerial responsibilities

The Management Board of Captor Therapeutics S.A. based in Wrocław ("the Company") informs that on 27 January 2025 it received from Michał Walczak, Member of the Management Board, the notification regarding transactions on the Company's shares under Article 19(1) of the MAR Regulation.

The content of the notification is attached to this report.